LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 320 of 535
Next
>>
>
7976 to 8000 of 13356 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Normalized Growth Rate Inhibition Value
BT-20	PF431396	0.04	uM	LJP5	2	E12	72	hr	1097	3586	3877	0.9248	0.9159
BT-20	PF431396	0.04	uM	LJP5	3	E12	72	hr	1097	3510	3925	0.8942	0.8820
BT-20	PF431396	0.12	uM	LJP5	1	E11	72	hr	1097	3113	3735	0.8334	0.8041
BT-20	PF431396	0.12	uM	LJP5	2	E11	72	hr	1097	2650	3877	0.6834	0.6228
BT-20	PF431396	0.12	uM	LJP5	3	E11	72	hr	1097	3164	3925	0.8060	0.7787
BT-20	PF431396	0.37	uM	LJP5	1	E10	72	hr	1097	1862	3735	0.4985	0.3488
BT-20	PF431396	0.37	uM	LJP5	2	E10	72	hr	1097	1575	3877	0.4062	0.2195
BT-20	PF431396	0.37	uM	LJP5	3	E10	72	hr	1097	1782	3925	0.4540	0.3017
BT-20	PF431396	1.11	uM	LJP5	1	E09	72	hr	1097	1503	3735	0.4024	0.1949
BT-20	PF431396	1.11	uM	LJP5	2	E09	72	hr	1097	1191	3877	0.3071	0.0460
BT-20	PF431396	1.11	uM	LJP5	3	E09	72	hr	1097	1399	3925	0.3564	0.1412
BT-20	PF431396	3.33	uM	LJP5	1	E08	72	hr	1097	1383	3735	0.3703	0.1399
BT-20	PF431396	3.33	uM	LJP5	2	E08	72	hr	1097	1415	3877	0.3649	0.1499
BT-20	PF431396	3.33	uM	LJP5	3	E08	72	hr	1097	1269	3925	0.3233	0.0823
BT-20	PF431396	10	uM	LJP5	1	E07	72	hr	1097	735	3735	0.1968	-0.2029
BT-20	PF431396	10	uM	LJP5	2	E07	72	hr	1097	789	3877	0.2035	-0.1656
BT-20	PF431396	10	uM	LJP5	3	E07	72	hr	1097	817	3925	0.2081	-0.1482
BT-20	Celastrol	0.04	uM	LJP6	1	G12	72	hr	1097	4214	3610	1.1671	1.1882
BT-20	Celastrol	0.04	uM	LJP6	2	G12	72	hr	1097	3869	3713	1.0418	1.0471
BT-20	Celastrol	0.04	uM	LJP6	3	G12	72	hr	1097	3835	3696	1.0375	1.0425
BT-20	Celastrol	0.12	uM	LJP6	1	G11	72	hr	1097	4151	3610	1.1497	1.1691
BT-20	Celastrol	0.12	uM	LJP6	2	G11	72	hr	1097	3901	3713	1.0504	1.0567
BT-20	Celastrol	0.12	uM	LJP6	3	G11	72	hr	1097	3753	3696	1.0153	1.0174
BT-20	Celastrol	0.37	uM	LJP6	1	G10	72	hr	1097	3324	3610	0.9206	0.9060
BT-20	Celastrol	0.37	uM	LJP6	2	G10	72	hr	1097	3080	3713	0.8294	0.7982

|<
<<
Previous
Page 320 of 535
Next
>>
>
7976 to 8000 of 13356 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)